OrganoClick AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 21.63 million compared to SEK 17.95 million a year ago. Net loss was SEK 20.57 million compared to SEK 11.86 million a year ago.

Basic loss per share from continuing operations was SEK 0.21 compared to SEK 0.12 a year ago.